Mild Cognitive Impairment
Лёгкие когнитивные нарушения
2009-12-01
SCID: 54.1/fcxz9ebb
Discuss with AI
Alzheimer diseaseMild cognitive impairmentbiomarkersclinical trialsneuroimaging
Figures from the paper
Abstract (AI)
In the past 10 years, there has been a virtual explosion in the literature concerning the construct of mild cognitive impairment. The interest in this topic demonstrates the increasing emphasis on the identification of the earliest features of cognitive disorders such as Alzheimer disease and other dementias. Mild cognitive impairment represents the earliest clinical features of these conditions and, hence, has become a focus of clinical, epidemiologic, neuroimaging, biomarker, neuropathological, disease mechanism, and clinical trials research. This review summarizes the progress that has been made while also recognizing the challenges that remain.
Key Findings
1
Despite substantial progress summarized in the review, significant challenges in understanding and addressing MCI remain.
2
MCI has become a major focus across clinical, epidemiologic, neuroimaging, biomarker, neuropathological, disease mechanism, and clinical trials research.
3
MCI represents the earliest clinical features of Alzheimer disease and other dementias, making early identification a priority.
4
Research on mild cognitive impairment (MCI) has expanded dramatically over the past 10 years.
Research Object
Mild cognitive impairment (MCI)
Research Subject
The early clinical features, identification, and characterization of MCI as the prodromal stage of Alzheimer disease and other dementias across clinical, epidemiologic, neuroimaging, biomarker, neuropathological, disease-mechanism, and clinical-trial perspectives
Publication Details
Publication Date
2009-12-01
Journal
Publisher
ISSN
Access Type
Author Information
Download PDF
Subscribe to digest